Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans (original) (raw)

• Shevach, E. M. From vanilla to 28 flavors: multiple varieties of T regulatory cells. Immunity 25, 195–201 (2006).
  Article CAS PubMed Google Scholar
• Groux, H. et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389, 737–742 (1997). In this paper, both human and mouse IL-10-producing T R 1 cells were characterized for the first time.
  Article CAS PubMed Google Scholar
• Walker, M. R. et al. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25− T cells. J. Clin. Invest. 112, 1437–1443 (2003).
  Article CAS PubMed Google Scholar
• Sakaguchi, S., Setoguchi, R., Yagi, H. & Nomura, T. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in self-tolerance and autoimmune disease. Curr. Top. Microbiol. Immunol. 305, 51–66 (2006).
  CAS PubMed Google Scholar
• Taams, L. S. et al. Antigen-specific T cell suppression by human CD4+CD25+ regulatory T cells. Eur. J. Immunol. 32, 1621–1630 (2002).
  Article CAS PubMed Google Scholar
• Wing, K. et al. CD4 T cell activation by myelin oligodendrocyte glycoprotein is suppressed by adult but not cord blood CD25+ T cells. Eur. J. Immunol. 33, 579–587 (2003).
  Article CAS PubMed Google Scholar
• Danke, N. A., Koelle, D. M., Yee, C., Beheray, S. & Kwok, W. W. Autoreactive T cells in healthy individuals. J. Immunol. 172, 5967–5972 (2004).
  Article CAS PubMed Google Scholar
• Kitani, A., Chua, K., Nakamura, K. & Strober, W. Activated self-MHC-reactive T cells have the cytokine phenotype of Th3/T regulatory cell 1 T cells. J. Immunol. 165, 691–702 (2000).
  Article CAS PubMed Google Scholar
• Arif, S. et al. Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. J. Clin. Invest. 113, 451–463 (2004). This is the first study providing evidence that patients with type 1 diabetes have reduced numbers of circulating islet-specific T R 1 cells compared with HLA-matched healthy controls.
  Article CAS PubMed PubMed Central Google Scholar
• Baecher-Allan, C. & Hafler, D. A. Human regulatory T cells and their role in autoimmune disease. Immunol. Rev. 212, 203–216 (2006).
  Article CAS PubMed Google Scholar
• Yudoh, K., Matsuno, H., Nakazawa, F., Yonezawa, T. & Kimura, T. Reduced expression of the regulatory CD4+ T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis. Arthritis Rheum. 43, 617–627 (2000).
  Article CAS PubMed Google Scholar
• Miura, Y. et al. Association of Foxp3 regulatory gene expression with graft-versus-host disease. Blood 104, 2187–2193 (2004). This study shows for the first time a significant reduction of FOXP3 mRNA levels in PBMCs from patients with GVHD compared with those without GVHD.
  Article CAS PubMed Google Scholar
• Rezvani, K. et al. High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT. Blood 108, 1291–1297 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Zorn, E. et al. Reduced frequency of FOXP3+CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease. Blood 106, 2903–2911 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Clark, F. J. et al. Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cells. Blood 103, 2410–2416 (2004).
  Article CAS PubMed Google Scholar
• Meignin, V. et al. Numbers of Foxp3-expressing CD4+CD25high T cells do not correlate with the establishment of long-term tolerance after allogeneic stem cell transplantation. Exp. Hematol. 33, 894–900 (2005).
  Article CAS PubMed Google Scholar
• Rieger, K. et al. Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD. Blood 107, 1717–1723 (2006).
  Article CAS PubMed Google Scholar
• Meloni, F. et al. Monocyte chemoattractant protein-1 levels in bronchoalveolar lavage fluid of lung-transplanted patients treated with tacrolimus as rescue treatment for refractory acute rejection. Transplant Proc. 35, 1523–1526 (2003).
  Article CAS PubMed Google Scholar
• Demirkiran, A. et al. Low circulating regulatory T-cell levels after acute rejection in liver transplantation. Liver Transpl. 12, 277–284 (2006).
  Article PubMed Google Scholar
• Salama, A. D., Najafian, N., Clarkson, M. R., Harmon, W. E. & Sayegh, M. H. Regulatory CD25+ T cells in human kidney transplant recipients. J. Am. Soc. Nephrol. 14, 1643–1651 (2003).
  Article PubMed Google Scholar
• Bacchetta, R. et al. High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J. Exp. Med. 179, 493–502 (1994). This study describes the successful isolation of CD4+ host-reactive T-cell clones from SCID patients transplanted with allogeneic HSCs, which produce high amounts of IL-10 in the absence of IL-4 after antigen-specific stimulation in vitro . The presence of these IL-10-producing CD4+ T cells correlated with the absence of GVHD and long-term tolerance.
  Article CAS PubMed Google Scholar
• Baker, K. et al. High spontaneous IL-10 production in unrelated bone marrow transplant recipients is associated with fewer transplant-related complications and early deaths. Bone Marrow Transplant. 23, 1123–1129 (1999).
  Article CAS PubMed Google Scholar
• Weston, L. E., Geczy, A. F. & Briscoe, H. Production of IL-10 by alloreactive sibling donor cells and its influence on the development of acute GVHD. Bone Marrow Transplant. 37, 207–212 (2006).
  Article CAS PubMed Google Scholar
• VanBuskirk, A. M. et al. Human allograft acceptance is associated with immune regulation. J. Clin. Invest. 106, 145–155 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Bacchetta, R. et al. Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J. Clin. Invest. 116, 1713–1722 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Marangoni, F. et al. WASP regulates suppressor activity of human and murine CD4+CD25+FOXP3+ natural regulatory T cells. J. Exp. Med. 204, 369–380 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Kriegel, M. A. et al. Defective suppressor function of human CD4+ CD25+ regulatory T cells in autoimmune polyglandular syndrome type II. J. Exp. Med. 199, 1285–1291 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Bleesing, J. J. et al. Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome. Blood 98, 2466–2473 (2001).
  Article CAS PubMed Google Scholar
• Mottet, C., Uhlig, H. H. & Powrie, F. Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J. Immunol. 170, 3939–3943 (2003).
  Article CAS PubMed Google Scholar
• Tang, Q. et al. _In vitro_-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 199, 1455–1465 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Tarbell, K. V. et al. Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice. J. Exp. Med. 204, 191–201 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Hanash, A. M. & Levy, R. B. Donor CD4+CD25+ T cells promote engraftment and tolerance following MHC-mismatched hematopoietic cell transplantation. Blood 105, 1828–1836 (2005).
  Article CAS PubMed Google Scholar
• Joffre, O., Gorsse, N., Romagnoli, P., Hudrisier, D. & van Meerwijk, J. P. Induction of antigen-specific tolerance to bone marrow allografts with CD4+CD25+ T lymphocytes. Blood 103, 4216–4221 (2004).
  Article CAS PubMed Google Scholar
• Taylor, P. A. et al. L-selectinhi but not the L-selectinlo CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection. Blood 104, 3804–3812 (2004).
  Article CAS PubMed Google Scholar
• Cohen, J. L., Trenado, A., Vasey, D., Klatzmann, D. & Salomon, B. L. CD4+CD25+ immunoregulatory T cells: new therapeutics for graft-versus-host disease. J. Exp. Med. 196, 401–406 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Hoffmann, P., Ermann, J., Edinger, M., Fathman, C. G. & Strober, S. Donor-type CD4+CD25+ regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J. Exp. Med. 196, 389–399 (2002). References 35, 36 and 96 are the first to show that the adoptive transfer of CD4+CD25+ regulatory T cells significantly delays or even prevents GVHD in preclinical mouse models of BMT.
  Article CAS PubMed PubMed Central Google Scholar
• Trenado, A. et al. Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. J. Clin. Invest. 112, 1688–1696 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Zeller, J. C. et al. Induction of CD4+ T cell alloantigen-specific hyporesponsiveness by IL-10 and TGF-β. J. Immunol. 163, 3684–3691 (1999).
  CAS PubMed Google Scholar
• Gregori, S. et al. Regulatory T cells induced by 1α,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J. Immunol. 167, 1945–1953 (2001).
  Article CAS PubMed Google Scholar
• Lee, M. K. 4th. et al. Promotion of allograft survival by CD4+CD25+ regulatory T cells: evidence for in vivo inhibition of effector cell proliferation. J. Immunol. 172, 6539–6544 (2004).
  Article CAS PubMed Google Scholar
• Battaglia, M., Stabilini, A. & Roncarolo, M. G. Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood 105, 4743–4748 (2005). In this study, we showed, for the first time, that rapamycin has the ability to allow the selective proliferation of T Reg cells.
  Article CAS PubMed Google Scholar
• Battaglia, M. et al. Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance. Diabetes 55, 40–49 (2006).
  Article CAS PubMed Google Scholar
• Waldmann, H., Adams, E., Fairchild, P. & Cobbold, S. Infectious tolerance and the long-term acceptance of transplanted tissue. Immunol. Rev. 212, 301–313 (2006).
  Article CAS PubMed Google Scholar
• Barrat, F. J. et al. In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 195, 603–616 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Hoffmann, P. et al. Isolation of CD4+CD25+ regulatory T cells for clinical trials. Biol. Blood Marrow Transplant. 12, 267–274 (2006).
  Article CAS PubMed Google Scholar
• Hoffmann, P., Eder, R., Kunz-Schughart, L. A., Andreesen, R. & Edinger, M. Large-scale in vitro expansion of polyclonal human CD4+CD25high regulatory T cells. Blood 104, 895–903 (2004).
  Article CAS PubMed Google Scholar
• Levings, M. K. et al. Human CD25+CD4+ T suppressor cell clones produce transforming growth factor β, but not interleukin 10, and are distinct from type 1 T regulatory cells. J. Exp. Med. 196, 1335–1346 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Battaglia, M. et al. Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients. J. Immunol. 177, 8338–8347 (2006).
  Article CAS PubMed Google Scholar
• Liu, W. et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J. Exp. Med. 203, 1701–1711 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Seddiki, N. et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med. 203, 1693–1700 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Jiang, S., Camara, N., Lombardi, G. & Lechler, R. I. Induction of allopeptide-specific human CD4+CD25+ regulatory T cells ex vivo. Blood 102, 2180–2186 (2003). References 50 and 51 show that CD4+CD25+ T Reg cells are CD127 low/− and open new venues for a better isolation and purification of T Reg cells.
  Article CAS PubMed Google Scholar
• Roncarolo, M. G. et al. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol. Rev. 212, 28–50 (2006).
  Article CAS PubMed Google Scholar
• Battaglia, M. & Roncarolo, M. G. Induction of transplantation tolerance via regulatory T cells. Inflamm. Allergy Drug Targets 5, 157–165 (2006).
  Article CAS PubMed Google Scholar
• Zeiser, R. et al. Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production. Blood 108, 390–399 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Achenbach, P., Bonifacio, E. & Ziegler, A. G. Predicting type 1 diabetes. Curr. Diab. Rep. 5, 98–103 (2005).
  Article CAS PubMed Google Scholar
• Ermann, J. et al. Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD. Blood 105, 2220–2226 (2005).
  Article CAS PubMed Google Scholar
• Nguyen, V. H. et al. In vivo dynamics of regulatory T cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation. Blood 109, 2649–2656 (2007).
  Article CAS PubMed Google Scholar
• Misra, N., Bayry, J., Lacroix-Desmazes, S., Kazatchkine, M. D. & Kaveri, S. V. Cutting edge: human CD4+CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells. J. Immunol. 172, 4676–4680 (2004).
  Article CAS PubMed Google Scholar
• Venet, F. et al. Human CD4+CD25+ regulatory T lymphocytes inhibit lipopolysaccharide-induced monocyte survival through a Fas/Fas ligand-dependent mechanism. J. Immunol. 177, 6540–6547 (2006).
  Article CAS PubMed Google Scholar
• Taams, L. S. et al. Modulation of monocyte/macrophage function by human CD4+CD25+ regulatory T cells. Hum. Immunol. 66, 222–230 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Lewkowicz, P., Lewkowicz, N., Sasiak, A. & Tchorzewski, H. Lipopolysaccharide-activated CD4+CD25+ T regulatory cells inhibit neutrophil function and promote their apoptosis and death. J. Immunol. 177, 7155–7163 (2006).
  Article CAS PubMed Google Scholar
• Wood, K. J. & Sawitzki, B. Interferon γ: a crucial role in the function of induced regulatory T cells in vivo. Trends Immunol. 27, 183–187 (2006).
  Article CAS PubMed Google Scholar
• Farrar, M. A. & Schreiber, R. D. The molecular cell biology of interferon-γ and its receptor. Annu. Rev. Immunol. 11, 571–611 (1993).
  Article CAS PubMed Google Scholar
• Tang, Q. et al. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nature Immunol. 7, 83–92 (2006).
  Article CAS Google Scholar
• Sarween, N. et al. CD4+CD25+ cells controlling a pathogenic CD4 response inhibit cytokine differentiation, CXCR-3 expression, and tissue invasion. J. Immunol. 173, 2942–2951 (2004).
  Article CAS PubMed Google Scholar
• Chen, Z., Herman, A. E., Matos, M., Mathis, D. & Benoist, C. Where CD4+CD25+ T reg cells impinge on autoimmune diabetes. J. Exp. Med. 202, 1387–1397 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Roncarolo, M. G., Battaglia, M. & Gregori, S. The role of interleukin 10 in the control of autoimmunity. J. Autoimmun. 20, 269–272 (2003).
  Article CAS PubMed Google Scholar
• Peng, Y., Laouar, Y., Li, M. O., Green, E. A. & Flavell, R. A. TGF-β regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes. Proc. Natl Acad. Sci. USA 101, 4572–4577 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Battaglia, M. et al. Induction of tolerance in type 1 diabetes via both CD4+CD25+ T regulatory cells and T regulatory type 1 cells. Diabetes 55, 1571–1580 (2006).
  Article CAS PubMed Google Scholar
• Chen, C., Lee, W. H., Zhong, L. & Liu, C. P. Regulatory T cells can mediate their function through the stimulation of APCs to produce immunosuppressive nitric oxide. J. Immunol. 176, 3449–3460 (2006).
  Article CAS PubMed Google Scholar
• Battaglia, M., Gregori, S., Bacchetta, R. & Roncarolo, M. G. Tr1 cells: from discovery to their clinical application. Semin. Immunol. 18, 120–127 (2006).
  Article CAS PubMed Google Scholar
• Sakaguchi, S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nature Immunol. 6, 345–352 (2005).
  Article CAS Google Scholar
• Allan, S. E. et al. The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs. J. Clin. Invest. 115, 3276–3284 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Singh, B. et al. Control of intestinal inflammation by regulatory T cells. Immunol. Rev. 182, 190–200 (2001).
  Article CAS PubMed Google Scholar
• Shevach, E. M. et al. The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells. Immunol. Rev. 212, 60–73 (2006).
  Article CAS PubMed Google Scholar
• Scheffold, A., Hühn, J. & Höfer, T. Regulation of CD4+CD25+ regulatory T cell activity: it takes (IL-) two to tango. Eur. J. Immunol. 35, 1336–1341 (2005).
  Article CAS PubMed Google Scholar
• Levings, M. K. et al. Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells. Blood 105, 1162–1169 (2005).
  Article CAS PubMed Google Scholar
• Levings, M. K. et al. IFN-α and IL-10 induce the differentiation of human type 1 T regulatory cells. J. Immunol. 166, 5530–5539 (2001).
  Article CAS PubMed Google Scholar
• Ziegler, S. F. FOXP3: of mice and men. Annu. Rev. Immunol. 24, 209–226 (2006).
  Article CAS PubMed Google Scholar
• Khattri, R., Cox, T., Yasayko, S. A. & Ramsdell, F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nature Immunol. 4, 337–342 (2003).
  Article CAS Google Scholar
• Gondek, D. C., Lu, L. F., Quezada, S. A., Sakaguchi, S. & Noelle, R. J. Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J. Immunol. 174, 1783–1786 (2005).
  Article CAS PubMed Google Scholar
• Zhao, D. M., Thornton, A. M., DiPaolo, R. J. & Shevach, E. M. Activated CD4+CD25+ T cells selectively kill B lymphocytes. Blood 107, 3925–3932 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Grossman, W. J. et al. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 21, 589–601 (2004).
  Article CAS PubMed Google Scholar
• Chen, D. et al. CD4+CD25+ regulatory T-cells inhibit the islet innate immune response and promote islet engraftment. Diabetes 55, 1011–1021 (2006).
  Article CAS PubMed Google Scholar
• Ding, Q. et al. B7H1-Ig fusion protein activates the CD4+ IFN-γ receptor+ type 1 T regulatory subset through IFN-γ-secreting Th1 cells. J. Immunol. 177, 3606–3614 (2006).
  Article CAS PubMed Google Scholar
• Tarbell, K. V., Yamazaki, S., Olson, K., Toy, P. & Steinman, R. M. CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J. Exp. Med. 199, 1467–1477 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Masteller, E. L. et al. Expansion of functional endogenous antigen-specific CD4+CD25+ regulatory T cells from nonobese diabetic mice. J. Immunol. 175, 3053–3059 (2005).
  Article CAS PubMed Google Scholar
• Chen, C., Lee, W. H., Yun, P., Snow, P. & Liu, C. P. Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes. J. Immunol. 171, 733–744 (2003).
  Article CAS PubMed Google Scholar
• You, S. et al. Presence of diabetes-inhibiting, glutamic acid decarboxylase-specific, IL-10-dependent, regulatory T cells in naive nonobese diabetic mice. J. Immunol. 173, 6777–6785 (2004).
  Article CAS PubMed Google Scholar
• Hori, S., Haury, M., Coutinho, A. & Demengeot, J. Specificity requirements for selection and effector functions of CD25+4+ regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice. Proc. Natl Acad. Sci. USA 99, 8213–8218 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Kohm, A. P., Carpentier, P. A., Anger, H. A. & Miller, S. D. Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. 169, 4712–4716 (2002).
  Article CAS PubMed Google Scholar
• Morgan, M. E. et al. Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis Rheum. 52, 2212–2221 (2005).
  Article CAS PubMed Google Scholar
• Cong, Y., Weaver, C. T., Lazenby, A. & Elson, C. O. Bacterial-reactive T regulatory cells inhibit pathogenic immune responses to the enteric flora. J. Immunol. 169, 6112–6119 (2002).
  Article CAS PubMed Google Scholar
• Scalapino, K. J., Tang, Q., Bluestone, J. A., Bonyhadi, M. L. & Daikh, D. I. Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells. J. Immunol. 177, 1451–1459 (2006).
  Article CAS PubMed Google Scholar
• Fontenot, J. D., Gavin, M. A. & Rudensky, A. Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nature Immunol. 4, 330–336 (2003).
  Article CAS Google Scholar
• Taylor, P. A., Lees, C. J. & Blazar, B. R. The infusion of ex vivo activated and expanded CD4+CD25+ immune regulatory cells inhibits graft-versus-host disease lethality. Blood 99, 3493–3499 (2002).
  Article CAS PubMed Google Scholar